Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Andrew W Roberts

Showing results (61-70 of 198) with videos related to

Pageof 20
Sort By:
Clinical and Applied Thrombosis/Hemostasis : Official Journal of the International Academy of Clinical and Applied Thrombosis/Hemostasis|March 25, 2024
Outcomes and Costs in Patients with Immune Thrombotic Thrombocytopenic Purpura Receiving Front-Line Versus Delayed Caplacizumab: A US Hospital Database StudyAlix Arnaud, Samantha Schilsky, Jackie Lucia, et al.
Journal of the National Cancer Institute|October 13, 2019
Concurrent Opioid and Benzodiazepine Prescriptions Among Older Women Diagnosed With Breast CancerDevon K Check, Aaron N Winn, Nicole Fergestrom, et al.
Proceedings of the National Academy of Sciences of the United States of America|July 24, 2004
Critical role for granulocyte colony-stimulating factor in inflammatory arthritisKate E Lawlor, Ian K Campbell, Donald Metcalf, et al.
JAMA Internal Medicine|August 7, 2023
Buprenorphine Out-of-Pocket Costs and Discontinuation in Privately Insured Adults With Opioid Use DisorderAshley A Leech, Elizabeth McNeer, Andrew W Roberts, et al.
British Journal of Haematology|May 29, 2010
Improved survival for relapsed diffuse large B cell lymphoma is predicted by a negative pre-transplant FDG-PET scan following salvage chemotherapyMichael Dickinson, Rosemary Hoyt, Andrew W Roberts, et al.
Health Affairs (Project Hope)|October 6, 2016
Controlled Substance Lock-In Programs: Examining An Unintended Consequence Of A Prescription Drug Abuse PolicyAndrew W Roberts, Joel F Farley, G Mark Holmes, et al.
Growth Factors (Chur, Switzerland)|November 19, 2009
Regulation of multiple cytokine signalling pathways by SOCS3 is independent of SOCS2Hiu Kiu, Christopher J Greenhalgh, Anne Thaus, et al.
Blood|November 4, 2006
Pathologic consequences of STAT3 hyperactivation by IL-6 and IL-11 during hematopoiesis and lymphopoiesisBrendan J Jenkins, Andrew W Roberts, Claire J Greenhill, et al.
Journal of Managed Care & Specialty Pharmacy|October 30, 2014
North Carolina Medicaid recipient management lock-in program: the pharmacist's perspectiveS Rose Werth, Nidhi Sachdeva, Andrew W Roberts, et al.
Proceedings of the National Academy of Sciences of the United States of America|November 14, 2008
In vivo efficacy of the Bcl-2 antagonist ABT-737 against aggressive Myc-driven lymphomasKylie D Mason, Cassandra J Vandenberg, Clare L Scott, et al.
Pageof 20

Showing results (61-70 of 198) with videos related to

Sort By:
Pageof 20
Clinical and Applied Thrombosis/Hemostasis : Official Journal of the International Academy of Clinical and Applied Thrombosis/Hemostasis|March 25, 2024
Outcomes and Costs in Patients with Immune Thrombotic Thrombocytopenic Purpura Receiving Front-Line Versus Delayed Caplacizumab: A US Hospital Database StudyAlix Arnaud, Samantha Schilsky, Jackie Lucia, et al.
Journal of the National Cancer Institute|October 13, 2019
Concurrent Opioid and Benzodiazepine Prescriptions Among Older Women Diagnosed With Breast CancerDevon K Check, Aaron N Winn, Nicole Fergestrom, et al.
Proceedings of the National Academy of Sciences of the United States of America|July 24, 2004
Critical role for granulocyte colony-stimulating factor in inflammatory arthritisKate E Lawlor, Ian K Campbell, Donald Metcalf, et al.
JAMA Internal Medicine|August 7, 2023
Buprenorphine Out-of-Pocket Costs and Discontinuation in Privately Insured Adults With Opioid Use DisorderAshley A Leech, Elizabeth McNeer, Andrew W Roberts, et al.
British Journal of Haematology|May 29, 2010
Improved survival for relapsed diffuse large B cell lymphoma is predicted by a negative pre-transplant FDG-PET scan following salvage chemotherapyMichael Dickinson, Rosemary Hoyt, Andrew W Roberts, et al.
Health Affairs (Project Hope)|October 6, 2016
Controlled Substance Lock-In Programs: Examining An Unintended Consequence Of A Prescription Drug Abuse PolicyAndrew W Roberts, Joel F Farley, G Mark Holmes, et al.
Growth Factors (Chur, Switzerland)|November 19, 2009
Regulation of multiple cytokine signalling pathways by SOCS3 is independent of SOCS2Hiu Kiu, Christopher J Greenhalgh, Anne Thaus, et al.
Blood|November 4, 2006
Pathologic consequences of STAT3 hyperactivation by IL-6 and IL-11 during hematopoiesis and lymphopoiesisBrendan J Jenkins, Andrew W Roberts, Claire J Greenhill, et al.
Journal of Managed Care & Specialty Pharmacy|October 30, 2014
North Carolina Medicaid recipient management lock-in program: the pharmacist's perspectiveS Rose Werth, Nidhi Sachdeva, Andrew W Roberts, et al.
Proceedings of the National Academy of Sciences of the United States of America|November 14, 2008
In vivo efficacy of the Bcl-2 antagonist ABT-737 against aggressive Myc-driven lymphomasKylie D Mason, Cassandra J Vandenberg, Clare L Scott, et al.
Pageof 20